B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMD13

MOLECULAR TARGET

proteasome 26S subunit, non-ATPase 13

UniProt: Q9UNM6NCBI Gene: 57191 compounds

PSMD13 (proteasome 26S subunit, non-ATPase 13) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMD13

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.4811

About PSMD13 as a Drug Target

PSMD13 (proteasome 26S subunit, non-ATPase 13) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PSMD13 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMD13 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.